部分前期发表SCI文章如下：
1) Li Dongqing, Su Hang, Deng Xiaolin, Huang Yuan, Wang Zihuan, Zhang Jinge, Chen Chen, Zheng Zaosong, Wang Qiong, Zhao Shanchao, Chen Zhe-Sheng, Chen Haiyong, Hou Lina, Tan Wanlong, Li Fei. DARS2 Promotes Bladder Cancer Progression by Enhancing PINK1-Mediated Mitophagy. Int. J. Biol. Sci. 2025; 21(4): 1530-1544.IF=10.0
2) Cao Chun, Wang Yu, Deng Xiaolin, ZhaoXinlei, Chen Yuwen, Tan Wanlong, Deng Fan, Li Fei. Exosomes containing miR-152-3p targeting FGFR3 mediate SLC7A7- induced angiogenesis in bladder cancer. Npj Precis. Onc. 2025; 9(71).IF=8.0
3) Deng Xiaolin, Huang Yuan, Zhang Jinge, Chen Yuwen, Jiang Feifan, Zhang Zicai, Li Tanghua, Hou Lina, Tan Wanlong, Li Fei. Histone lactylation regulates PRKN-Mediated mitophagy to promote M2 Macrophage polarization in bladder cancer. Int Immunopharmacol. 2025;148:114119.IF=4.7
4）Zheng Zaosong, Zeng Xiangbo, Zhu Yuanchao, Leng Mengxin, Zhang Zhiyong, Wang Qiong, Liu Xiaocen, Zeng Siying, Xiao Yongyuan, Hu Chenxi, Pang Shiyu, Wang Tong, Xu Bihong, Peng Peidan, Li Fei, Tan Wanlong. CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis. Mol Cancer. 2024 Jan 6;23(1):4.IF=33.9
5) Li F, Zhang H, Huang Y, Li D, Zheng Z, Xie K, Cao C, Wang Q, Zhao X, Huang Z,Chen S, Chen H, Fan Q, Deng F, Hou L, Deng X, Tan W. Single-cell transcriptomeanalysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist Updat. 2024 Jan 19;73:101059.IF=24.3
6）Zeng Xiangbo, Chen Zhiliang, Zhu Yuanchao, Liu Lei, Zhang Zhiyong, Xiao Yongyuan, Wang Qiong, Pang Shiyu, Zhao Fengjin, Xu Bihong, Leng Mengxin, Liu Xiaocen, Hu Chenxi, Zeng Siying, Li Fei, Xie Wenlian, Tan Wanlong, Zheng Zaosong. O-GlcNAcylation regulation of RIPK1-dependent apoptosis dictates sensitivity to sunitinib in renal cell carcinoma. Drug Resist Updat. 2024 Nov;77:101150.IF=24.3
7）Hu Chenxi, Zheng Zaosong, Pang Shiyu, Zhu Yuanchao, Jie Jirong, Lai Zhuocheng, Zeng Xiangbo, Xiao Yongyuan, Chen Zhifeng, Zhao Jingjing, Du Yuejun, Li Fei, Wang Qiong, Tan Wanlong. Chimeric SFT2D2-TBX19 Promotes Prostate Cancer Progression by Encoding TBX19-202 Protein and Stabilizing Mitochondrial ATP Synthase through ATP5F1A Phosphorylation. Adv Sci (Weinh). 2024 Dec;11(48):e2408426.IF=14.1
8) Zhang Jinge, Huang Yuan, Tan Xing, Wang Zihuan, Zhang Shenlan, Chen Yuwen, Jiang Feifan, Tan Wanlong, Deng Xiaolin, Li Fei. Integrated analysis of multiple transcriptomic approaches and machine learning integration algorithms reveals high endothelial venules as a prognostic immune-related biomarker in bladder cancer. Int Immunopharmacol, 2024; 136:112184. (通讯作者)IF=4.7
9) Li Fei, Zheng Zhaoson, Chen Wei, Li Ddonqing, Zhang Hhenghui, Zhu Yuanchao, Mo Qixing, Zhao Xinlei, Fan Qing, Deng Fan, HanConghui, Tan Wanglong. Regulation of cisplatin resistance in bladder cancer by epigeneticmechanisms. Drug Resist Updat. 2023; 68:100938.IF=24.3
10） Wang Y, Xie K, Chen W, Fang Y, Mo Q, Zhang H, Zhao X, Li D, Tan W, Zhao P,Li F. Synergistic ferroptosis-starvation therapy for bladder cancer based on hyaluronic acid modified metal-organic frameworks. Bioeng Transl Med. 2023 Mar 22;8(3):e10515.IF=10.711
11) Li Fei, Zhang Henghui, Wang Yu, Yao Zhihao, XieKunfen, Mo Qixing, Fan Qing, Hou Lina, Deng Fan, Tan Wanglong.FGFBP1 as a potential biomarker predicting bacillus Calmette-Guérin response inbladder cancer. Front Immunol. 2022; 13: 954836.IF=8.787
12) Yao Zhihao, Zhang Henghui, Zhang Xuejun, Zhang Zhiyong, JieJirong, XieKunfeng,Li Fei(Co-corresponding author),Tan Wanlong. Identificationof tumor microenvironmentrelated signature for predicting prognosis andimmunotherapy response in patients with bladder cancer. Front Genet. 2022;13:923768.IF=4.772
13) Li Fei, Wang Yu, XieKunfeng, Fang Yunze, Du Yuejun, Hou Lina, Tan Wanlong. The efficacy and safety ofPD-1/PD-L1 immune checkpoint inhibitors in treating advanced urothelial cancer:a meta-analysis of clinical trials. Aging (Albany NY). 2021；13(16):20468-20480.IF=5.955
14) Li Fei, XieWeiwei，FangYunze，XieKunfeng，LiuWendong，HouLina，TanWanlong，HnRNP-F promotes the proliferation of bladder cancer cells mediated by PI3K/AKT/ FOXO1, Journal of Cancer, 2021;12(1):281-291.IF=4.478
15) Li Fei, Xie Weiwei, Fang Yunze, Xie Kunfeng, Liu Wendong, Hou Lina, Tan Wanlong. HnRNP-F promotes the proliferation of bladder cancer cells mediated by PI3K/AKT/FOXO1. J Cancer. 2021 Jan 1;12(1):281-291.IF=3.2
16) Li Fei, ZhaoHongfan, SuMingqiang,Xie Weiwei,Fang Yunze,Du Yuejun,Yu Zhe,Hou Lina, Tan Wanlong, HnRNP-Fregulates EMT in bladder cancer by mediating the stabilization of Snail1 mRNA by binding to its 3' UTR. EBioMedicine,2019;45:208-219.IF=11.1
17) Li Fei, SuMingqiang, Zhao Hongfan, Xie Weiwei,Cao Sai,Wang Lili,Hou Lina, Tan Wanlong, HnRNP-Fpromotescellproliferation byregulatingTPX2inbladdercancer. Am J Transl Res,2019;11(11):7035-7048.IF=6.166
18) Li Fei, Yu Zhe, Chen Pengliang, Lin Guangzheng, Li Tieqiu, Hou Lina, Du Yuejun,TanWanlong, The increased excretion of urinary orosomucoid 1 as a useful biomarker for bladder cancer. Am J Cancer Res, 2016;6(2):p.331-340.IF=6.166
19) Li Fei, Zhou You, Hu Ruiting, Hou Lina, Du Yuejun, Zhang Xinji, OlkkonenVesa M, Tan Wanlong, Egg consumption and risk of bladder cancer: a meta-analysis. Nutr Cancer, 2013;65(4):538-546.IF=2.9
20) Li Fei, Chen Ding-nan, He Cheng-wu, Zhou You, OlkkonenVesa M., He Nan, Chen Wei, Wan Pei, Chen San-san, Zhu Yong-tong, Lan Kai-jian, Tan Wan-long. Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE). J Proteomics. 2012;77:225–36.IF=4.088